FDA grants breakthrough device designation for two renal denervation devices as companies race to be first on the market

Between 2009 and 2010, renal denervation was considered to be one of the most groundbreaking medical treatments discovered, potentially offering a solution for the largely untreated hypertensive population. Credit: Davizro Photography/Shutterstock.